Pernix Therapeutics Holdings Inc (NASDAQ:PTX), a specialty pharmaceutical company, today announced the completion of a new three-year $50 million revolving credit facility with Wells …
In a research report published yesterday, Brean Capital analyst Difei Yang reiterated a Buy rating on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX) with …
Pernix Therapeutics Holdings Inc (NASDAQ:PTX), a specialty pharmaceutical company, today announced positive results from Category 1 (in vitro) abuse deterrence studies with ZX007, utilizing …
In a research report issued today, Brean Capital analyst Difei Yang shared her expectations on Pernix Therapeutics Holdings Inc (NASDAQ:PTX), ahead of the company’s upcoming …
El Pollo LoCo Holdings Inc (NASDAQ:LOCO) slipped 13.11 percent to $25.
Cantor’s healthcare analyst Irina Rivkind Koffler weighed in with a cautious stance on shares of Pernix Therapeutics Holdings Inc (NASDAQ:PTX), reducing the price target to $8.50 (from $11.
